<DOC>
	<DOCNO>NCT01368419</DOCNO>
	<brief_summary>This study explore clinical efficacy continuous Endostar infusion combine radiotherapy esophageal cancer patient .</brief_summary>
	<brief_title>Continuous Endostar Infusion Combined With Radiotherapy Esophageal Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Histological cytological diagnosis previously untreated stage IIII esophageal cancer Measurable disease accord RECIST criterion ECOG Performance Status 01 The length esophageal carcinoma ≤ 10 cm Hematologic function : WBC ≥ 4.0×109/L , PLT ≥ 80×109/L , Hb ≥ 90g/L Renal function : Cr ≤ 2.0×UNL Hepatic function : BIL ≤ 2.0×UNL , ALT/AST ≤ 5.0×UNL Pregnant lactate woman Evidence bleed diathesis , serious infection Serious cardiovascular disease ( congestive heart failure , uncontrollable arrhythmia , unstable angina , myocardial infarction , serious heart valve disease , resistant hypertension ) Uncontrollable mental nervous disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Endostar</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Esophageal Cancer</keyword>
</DOC>